Stryker price target raised to $370 from $366 at UBS

UBS analyst Danielle Antalffy raised the firm’s price target on Stryker (SYK) to $370 from $366 and keeps a Neutral rating on the shares. Stryker reported a topline beat, and for 2025, the firm sees growth driven by new product launches, contribution from M&A activity with roughly 7 deals in the pipeline expected to contribute to growth and continued ramp of Mako especially amid two new indications, the analyst tells investors in a research note. The firm remains on the sidelines until it has conviction in sales and EPS upside vs. the Street.